Dr Thomas Exner

Dr Thomas Exner

Job Title: 
Chief Scientific Officer (CSO)

Dr Thomas Exner is responsible for the scientific planning, execution and supervision of different commercial project in the area of data management and integrated testing strategy development for risk/safety assessment of chemicals, drugs and nano materials. Additionally, he is coordinating the H2020 e-infrastructure project OpenRiskNet, is work package leader in the ACEnano and NanoCommons project, leads the creation of a knowledge infrastructure in the EU-ToxRisk project as well as functions as principal investigator in the Marie Skłodowska-Curie Innovative Training Network in3.

He studied chemistry and did his PhD in physical chemistry at the Technische Universität Darmstadt. After a postdoctoral stay at the University of Saskatchewan, Canada, he was appointed Assistant Professor at the University of Konstanz in 2003. In April 2012, he moved to the Institute of Pharmacy at the University of Tübingen and continued his research in close co-operation with the experimental and theoretical groups at the Institute until early 2015, when he moved to Douglas Connect.

Dr. Exner is the author and co-author of more than 50 articles in peer reviewed international journals and several other scientific contributions.

Latest Tweets

Edelweiss Connect (3 hours ago)
Edelweiss Connect and @Biopredic_Intl have organized a free joint workshop and hands-on training on HepaRG® cells,… https://t.co/LTtwmFxjGG
Edelweiss Connect (3 days ago)
RT @bigcat_UM: @mmarvinm2 and Trevor Levey (of the @EPA) who worked on a @openrisknet grant in the past three weeks and happy with the resu…
Edelweiss Connect (2 weeks ago)
#SaferWorldbyDesign = responsible innovation. Keep sustainable product development in mind from the R&D phases not… https://t.co/trzXIfvaxz
Edelweiss Connect (2 weeks ago)
To follow #3Rs, scientists need to rely more on a combination of #invitro and #insilico solutions. More data, stron… https://t.co/lF5Hfz9FCS
Edelweiss Connect (2 weeks ago)
Many current #invitro strategies are too expensive for small companies. Add #SaferSkin as a cost-effective way to… https://t.co/PBMs7ZjWy3

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 252 654 9003
  • Email: info@edelweissconnect.com